Testing eye drops and procedures after two-eye surgery
Part of Eyes & vision clinical trials.
This Phase 4 study looks at a treatment plan around the time of planned surgery on both eyes (called RLE). It may help the researchers learn how safe and effective the approach is for improving eye outcomes after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult who is planning surgery on both eyes (two-eye surgery).
- Your best corrected vision is 20/30 or better before surgery.
- You can attend required clinic visits and follow study procedures.
- You can and are willing to sign informed consent.
- You are between 22 and 75 years old (inclusive).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether Dextenza (a steroid pain-relief eye insert) can improve comfort after a specific type of retina surgery (pars plana vitrectomy). It looks at people getting surgery for conditions like macular hole, epiretinal membrane, or vitreomacular traction.
This trial compares two ways to prevent inflammation and comfort you after cataract surgery: usual antibiotic/steroid eye drops versus a “no-drops” option that is placed during surgery. It mainly looks at patient preference, comfort, and ease of treatment after surgery.
This study tests a special contact lens that slowly delivers anti-inflammatory/steroid medicine to the back of the eye. It aims to treat cystoid macular edema that keeps coming back and may improve vision for people who respond to steroid treatment.
This trial compares two ways to manage inflammation after corneal crosslinking for keratoconus: a tiny steroid insert placed in the tear duct versus standard steroid eye drops. It aims to see which option is easier and works just as well.
This trial studies whether DEXYCU is safe to use to reduce eye inflammation after cataract surgery in children. It aims to see if the medicine’s side effects are acceptable and whether it helps during normal recovery.
This trial looks at how to manage medicine around DMEK corneal transplant surgery to improve eye outcomes and safety. It may help people having this specific type of cornea transplant by testing an approach in the time after surgery.
Hear when a new Patient Preference trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.